BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1814748)

  • 1. Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: relation to tumor histology.
    Lipponen PK; Eskelinen MJ; Nordling S
    Eur Urol; 1991; 20(4):311-4. PubMed ID: 1814748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
    Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
    de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
    Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
    Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
    Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
    Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
    Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-diploid transitional cell carcinoma: a preliminary report.
    Chow NH; Tzai TS; Lin SN; Su WC; Cheng HL
    Int Urol Nephrol; 1994; 26(4):423-30. PubMed ID: 8002215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.
    Yokogi H; Wada Y; Moriyama-Gonda N; Igawa M; Ishibe T
    Br J Urol; 1996 Nov; 78(5):699-703. PubMed ID: 8976763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis: a report of 100 cases.
    Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
    J Urol; 1990 Oct; 144(4):879-83. PubMed ID: 2398562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy.
    Lipponen PK; Eskelinen MJ; Nordling S
    Eur J Cancer; 1991; 27(7):877-81. PubMed ID: 1834120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA aberrations of bladder mucosa in patients with transitional cell carcinomas.
    Høstmark JG; Laerum OD; Farsund T
    Scand J Urol Nephrol; 1984; 18(2):113-20. PubMed ID: 6463594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry.
    Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
    J Urol; 1990 Oct; 144(4):884-7. PubMed ID: 2398563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
    Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
    Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
    Jakobsen A; Mommsen S; Olsen S
    Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
    Wang Z
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.